A Pilot Study to Explore the Role of Gut Flora in Rheumatoid Arthritis

Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late Onset

NCT05808309 ·Status: WITHDRAWN

Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD

NCT05936970 ·Status: RECRUITING

Evolution of Intestinal Microbiota in Patients With Juvenile Spondylarthropathy According to Typology of Treatment

NCT04540432 ·Status: RECRUITING ·Phase: NA

Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis

NCT00321217 ·Status: UNKNOWN

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

NCT00414661 ·Status: COMPLETED

Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects

NCT00252668 ·Status: COMPLETED ·Phase: PHASE4

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

NCT01981473 ·Status: COMPLETED

Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

NCT00796705 ·Status: TERMINATED ·Phase: PHASE4

An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.

NCT02590562 ·Status: COMPLETED

Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis

NCT01111357 ·Status: COMPLETED

A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis

NCT00783536 ·Status: WITHDRAWN ·Phase: PHASE4

Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity

NCT05570513 ·Status: NOT_YET_RECRUITING

Study During Pregnancy of Expression of miRNAs in RA or SLE

NCT02350491 ·Status: COMPLETED

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

NCT00929357 ·Status: COMPLETED

Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

NCT01691014 ·Status: TERMINATED

Prediction of Methotrexate Response - A Pilot Study

NCT01726959 ·Status: COMPLETED

Rheumatoid Arthritis DMARD Intervention and UtilizationStudy

NCT00116727 ·Status: COMPLETED

Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy

NCT01083563 ·Status: TERMINATED

Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

NCT00848354 ·Status: COMPLETED ·Phase: PHASE4

Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research

NCT01617590 ·Status: UNKNOWN ·Phase: NA

A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis

NCT00976599 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood

NCT00781469 ·Status: TERMINATED

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

NCT03414502 ·Status: RECRUITING ·Phase: PHASE3

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

NCT01411215 ·Status: TERMINATED

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

NCT02878161 ·Status: UNKNOWN ·Phase: PHASE4